A study on non-coding RNA (Ribonucleic Acid) from prostate cancer patients has identified a series of new prostate cancer markers which can be found in urine. Combining these RNA markers into a single ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...

Indiana University is leading the way in the development of groundbreaking nanotechnology to revolutionize screening for prostate cancer, the second leading cause of cancer death among men in the ...

NucleoBio and PreCheck Health Services Announce Strategic Collaboration to Advance Non-Invasive Prostate Cancer Testing NucleoBio, Corp., a leading biotechnology innovator in precision oncology ...

“Prostate cancer remains one of the most challenging cancers for men worldwide, highlighting the urgent need for more accurate and non-invasive diagnostic tools. We believe that securing this ...

A new mobile prostate cancer screening bus will begin visiting neighborhoods this month, offering free screenings to raise awareness and promote early detection. The initiative, supported by the ...

Researchers have found a simple at home urine test for prostate cancer screening is highly accurate. Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine ...

* New urine biomarker test shows over 90% accuracy in detecting prostate cancer * Test works even when PSA levels appear normal * Biomarker levels drop after //surgery, confirming prostate origin ...

A know-how licensing agreement for a non-invasive electrochemical screening technology, based on research by Prof. A. L. Roy Vellaisamy, Chair Professor of Intelligent Systems in the School of Science ...

NFL tight ends and prostate cancer survivor Bruce Arians star in a Super Bowl commercial promoting a new, finger-free PSA ...

The prostate cancer diagnostics market size was estimated at USD 9.72 billion in 2025 and is projected to attain around USD 18 billion by 2035, growing at a notable CAGR of 6.36 % from 2026 to 2035.

Jeffrey Tosoian, MD, assistant professor of Urology and director of Translational Cancer Research at Vanderbilt University Medical Center. The results are important because this could enable at-home ...